A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic Tumors
Clinical trial NCT02699749 · COMPLETED
Trial details
- NCT number
- NCT02699749
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-24
- Primary completion
- 2019-12-21
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.